Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation
Open Access

[18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases

Joanna C. Porter, Balaji Ganeshan, Thida Win, Francesco Fraioli, Saif Khan, Manuel Rodriguez-Justo, Raymond Endozo, Robert I. Shortman, Luke R. Hoy, Toby M. Maher and Ashley M. Groves
Journal of Nuclear Medicine April 2024, 65 (4) 617-622; DOI: https://doi.org/10.2967/jnumed.123.266445
Joanna C. Porter
1CITR, UCL Respiratory, University College London, London, United Kingdom;
2Interstitial Lung Disease Centre, University College London Hospital, London, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Balaji Ganeshan
3Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thida Win
4Lister Hospital, North East Herts Trust, Stevenage, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Fraioli
3Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saif Khan
5Research Department of Pathology, University College London, and Department of Histopathology, University College London Hospital, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Rodriguez-Justo
5Research Department of Pathology, University College London, and Department of Histopathology, University College London Hospital, London, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raymond Endozo
3Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert I. Shortman
3Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luke R. Hoy
3Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toby M. Maher
6Keck School of Medicine, University of Southern California, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley M. Groves
3Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Immunohistochemical images of CD105 staining of microvessels in UIP (A and B) and non-UIP (C and D) at ×200 magnification (digital-based platform).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Representative participant [18F]FDG PET/CT scans showing high (A) and low (B) TBR of [18F]FDG uptake. Immunohistochemistry images of stained patient biopsies show high (C) and low (D) expression of CD105/endoglin (arrowheads).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Box plot highlighting increased distribution of CD105 in UIP vs. non-UIP histology (P = 0.011). *Patient 6 outlier (CD105 = 44). fLD = fibrotic lung disease.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Kaplan–Meier survival curve showing how neoangiogenic marker CD105 predicts overall survival (P = 0.041).

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Kaplan–Meier survival curve showing how vasculature marker CD31 predicts overall survival (P = 0.014).

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Scatterplot demonstrating positive correlation (Spearman rank correlation, 0.556; P < 0.05) between CD105 and [18F]FDG uptake (TBR).

Tables

  • Figures
    • View popup
    TABLE 1.

    Participant Characteristics, Immunohistochemistry Results, and [18F]FDG PET/CT Quantification*

    PatientForced vital capacity prediction (%)Transfer factor of lung for carbon monoxide prediction (%)HistologyTreatment for ILDCD105 (Va%/hpf)CD31 (Va%/hpf)GLUT-1 macrophage scoreTBRCD80 average of hpf countsCD163 average of hpf countsCD163:CD80 ratio
    16557UIPNo222605.2942.557.51.35
    25427NSIPNo192317.71NANANA
    34733OPNo101513NANANA
    45729NSIPNo103404.616.5754.55
    59979UIPNo233004.299.5343.58
    67341UIPNo44NA04.671.531.521
    7NA45UIPNoNANA262.558.523.4
    89564UIPNo183803.8632.552.51.62
    99166NSIPNoNA2915.2933361.09
    107747NSIPNo14NA03.3320.5512.49
    1110470UIPNo25NA14.64.58518.89
    129963UIPNo347005.8618.5653.51
    137554UIPNo172103.7510.5565.33
    1499NAUIPNoNA5526.337.531.54.2
    154343UIPNoNA4505.17351.517.17
    166363UIPNo2435010.29142.542.5
    17NANAUIPNoNANA26.17NANANA
    185840UIPNo194511211.5383.3
    • ↵* Lung function results were within 10 d of [18F]FDG PET/CT scan.

    • NSIP = nonspecific interstitial pneumonia; NA = not available; OP = organizing pneumonia.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (4)
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases
Joanna C. Porter, Balaji Ganeshan, Thida Win, Francesco Fraioli, Saif Khan, Manuel Rodriguez-Justo, Raymond Endozo, Robert I. Shortman, Luke R. Hoy, Toby M. Maher, Ashley M. Groves
Journal of Nuclear Medicine Apr 2024, 65 (4) 617-622; DOI: 10.2967/jnumed.123.266445

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases
Joanna C. Porter, Balaji Ganeshan, Thida Win, Francesco Fraioli, Saif Khan, Manuel Rodriguez-Justo, Raymond Endozo, Robert I. Shortman, Luke R. Hoy, Toby M. Maher, Ashley M. Groves
Journal of Nuclear Medicine Apr 2024, 65 (4) 617-622; DOI: 10.2967/jnumed.123.266445
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Relationship of Metabolic Activity and {alpha}v{beta}3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: A Preliminary Report
  • Google Scholar

More in this TOC Section

  • First-in-Human Study of 18F-Labeled PET Tracer for Glutamate AMPA Receptor [18F]K-40: A Derivative of [11C]K-2
  • Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
  • [11C]Carfentanil PET Whole-Body Imaging of μ-Opioid Receptors: A First in-Human Study
Show more Clinical Investigation

Similar Articles

Keywords

  • [18F]FDG PET/CT
  • ILD
  • fibrosis
  • angiogenesis
  • microvessel
SNMMI

© 2025 SNMMI

Powered by HighWire